Skip to main content
logo
Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.94
-0.27 (-3.74%)
At close: Aug 1, 2025, 4:00 PM
6.94
0.00 (0.02%)
After-hours: Aug 1, 2025, 7:58 PM EDT

Inozyme Pharma Revenue by Segment

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Access Fees
2.18B2.22B2.25B2.27B2.29B2.28B2.26B2.22B
Access Fees Growth
-4.59%-2.95%-0.72%2.37%5.80%8.49%11.50%14.42%
Other
369.03M354.35M343.59M336.53M330.48M319.89M317.33M244.92M
Other Growth
11.67%10.77%8.28%37.40%88.75%211.18%865.70%558.40%

Operating Metrics

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
US Integrated Care Members
102.50M93.80M93.90M92.40M91.80M89.60M90.20M85.90M-------------------
US Integrated Care Members Growth
11.66%4.69%4.10%7.57%8.13%7.56%10.13%--------------------
Visits
17.60M17.80M17.80M18.10M18.10M18.40M18.80M18.97M
Visits Growth
-2.76%-3.26%-5.32%-4.60%-4.39%-0.77%3.59%7.96%
Chronic Care Enrollment
1.15M1.20M1.18M1.17M1.12M1.16M1.12M1.07M-------------------
Chronic Care Enrollment Growth
2.68%3.89%5.08%9.32%9.05%13.64%12.99%--------------------
BetterHelp Paying Users
397.00K400.00K398.00K407.00K415.00K425.00K459.00K476.00K-------------------
BetterHelp Paying Users Growth
-4.34%-5.88%-13.29%-14.50%-11.13%-5.56%5.03%--------------------

Revenue by Geography

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021
US
2.14B2.16B2.19B2.22B2.24B2.24B2.23B2.19B
US Growth
-4.74%-3.48%-1.71%1.38%4.28%6.50%9.76%12.36%
International
415.48M409.62M400.28M386.85M376.21M365.26M352.79M339.26M
International Growth
10.44%12.14%13.46%14.03%17.84%19.43%20.05%20.09%

Operating Expense Breakdown

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Marketing
690.64M705.79M678.22M686.91M695.39M688.85M688.14M680.91M
Marketing Growth
-0.68%2.46%-1.44%0.88%4.30%10.48%16.62%30.38%
General and Administrative
436.57M435.49M444.45M445.92M462.21M464.66M475.55M472.37M
General and Administrative Growth
-5.55%-6.28%-6.54%-5.60%1.05%3.68%6.40%7.99%
Depreciation and Amortization
363.53M373.55M381.55M386.28M365.18M337.07M315.27M282.97M
Depreciation and Amortization Growth
-0.45%10.82%21.02%36.51%36.83%31.65%35.51%27.15%
Research and Development
295.84M307.27M320.46M332.37M342.92M348.52M341.51M345.04M
Research and Development Growth
-13.73%-11.83%-6.16%-3.67%1.29%2.81%3.83%7.37%
Sales
199.32M204.99M205.72M210.56M213.65M213.78M216.61M218.93M
Sales Growth
-6.71%-4.11%-5.03%-3.82%-4.33%-5.89%-5.91%-8.09%
Goodwill Impairment
59.14M-------
Acquisition and Integration
3.56M1.74M5.95M11.32M15.94M21.51M23.48M19.25M
Acquisition and Integration Growth
-77.68%-91.90%-74.66%-41.20%-6.55%37.71%73.22%18.08%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.